Visceral metastases are known to occur in advanced prostate cancer, usually when the tumour is resistant to androgen deprivation and, have worse outcomes regardless of therapies.
To analyse genomic alterations in tumour samples according to their lymphatic, bone, and visceral metastatic stages and overall survival.